共 125 条
[1]
Drossman DA(2006)The functional gastrointestinal disorders and the Rome III process Gastroenterology 130 1377-1390
[2]
Longstreth GF(2006)Functional bowel disorders Gastroenterology 130 1480-1491
[3]
Thompson WG(2008)Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits Am J Gastroenterol 103 2550-2561
[4]
Chey WD(2005)Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome Clin Gastroenterol Hepatol 3 349-357
[5]
Houghton LA(1998)Involvement of the 5-HT Am J Physiol 274 G827-G831
[6]
Mearin F(1996) receptor in CRH-induced defecation in rats Digestion 57 478-483
[7]
Spiller RC(1998)Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT Aliment Pharmacol Ther 12 849-855
[8]
Kanazawa M(1991) antagonism (Ondansetron) J Pharmacol Exp Ther 259 15-21
[9]
Palsson OS(1992)Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome J Pharmacol Exp Ther 261 297-303
[10]
Thiwan SO(1995)Pharmacologic profile of (R)-5-[(1-methyl-3-indolyl)carbonyl]-4,5,6,7-tetrahydro-1H-benzimidazole hydrochloride (YM060), a potent and selective 5-hydroxytryptamine3 receptor antagonist, and its enantiomer in the isolated tissue Jpn J Pharmacol 69 205-214